Meghan Thomas

Director Técnico/Científico/I+D en ARGENICA THERAPEUTICS LIMITED .

Consumer Services

Health Technology

Perfil

Meghan Thomas is currently Vice President-Clinical Development at Argenica Therapeutics Ltd. since 2022.
Formerly, Dr. Thomas was Vice President-Clinical Programs & Operations at Zelira Therapeutics Ltd. Education includes undergraduate and doctorate degrees from The University of Western Australia and an undergraduate degree from the University of Edith Cowan.

Cargos activos de Meghan Thomas

Empresas	Cargo	Inicio
ARGENICA THERAPEUTICS LIMITED	Director Técnico/Científico/I+D	04/04/2022

Todos los cargos activos de Meghan Thomas

Antiguos cargos conocidos de Meghan Thomas.

Empresas	Cargo	Fin
ZELIRA THERAPEUTICS LIMITED	Director de Operaciones	-

Ver el detalle de la experiencia de Meghan Thomas.

Formación de Meghan Thomas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Meghan Thomas.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
The University of Western Australia The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Edith Cowan University of Edith Cowan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Zelira Therapeutics Ltd. Zelira Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and supplies cannabinoid-based medicines for the treatment of human diseases and disorders	Health Technology
Argenica Therapeutics Ltd. Argenica Therapeutics Ltd. BiotechnologyHealth Technology Develops novel neuro protective therapeutics to reduce brain damage	Health Technology